Literature DB >> 32413046

Modulation of T helper 1 and T helper 2 immune balance in a murine stress model during Chlamydia muridarum genital infection.

Tesfaye Belay1, Elisha Martin1, Gezelle Brown1, Raenel Crenshaw1, Julia Street1, Ashleigh Freeman1, Shane Musick1, Tyler J Kinder1.   

Abstract

A murine model to study the effect of cold-induced stress (CIS) on Chlamydia muridarum genital infection and immune response has been developed in our laboratory. Previous results in the lab show that CIS increases the intensity of chlamydia genital infection, but little is known about the effects and mechanisms of CIS on the differentiation and activities of CD4+ T cell subpopulations and bone marrow-derived dendritic cells (BMDCs). The factors that regulate the production of T helper 1 (Th1) or T helper 2 (Th2) cytokines are not well defined. In this study, we examined whether CIS modulates the expressions of beta-adrenergic receptor (β-AR), transcription factors, hallmark cytokines of Th1 and Th2, and differentiation of BMDCs during C. muridarum genital infection in the murine model. Our results show that the mRNA level of the beta2-adrenergic receptor (β2-AR) compared to β1-AR and β3-AR was high in the mixed populations of CD4+ T cells and BMDCs. Furthermore, we observed decreased expression of T-bet, low level of Interferon-gamma (IFN-γ) production, increased expression of GATA-3, and Interleukin-4 (IL-4) production in CD4+ T cells of stressed mice. Exposure of BMDCs to Fenoterol, β2-AR agonist, or ICI118,551, β2-AR antagonist, revealed significant β2-AR stimulation or inhibition, respectively, in stressed mice. Moreover, co-culturing of mature BMDCs and naïve CD4+ T cells increased the production of IL-4, IL-10, L-17, and IL-23 cytokines, suggesting that stimulation of β2-AR leads to the increased production of Th2 cytokines. Overall, our results show for the first time that CIS promotes the switching from a Th1 to Th2 cytokine environment. This was evidenced in the murine stress model by the overexpression of GATA-3 concurrent with elevated IL-4 production, reduced T-bet expression, and IFN-γ secretion.

Entities:  

Year:  2020        PMID: 32413046      PMCID: PMC7228091          DOI: 10.1371/journal.pone.0226539

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  68 in total

1.  Immobilization increases norepinephrine release and reduces NK cytotoxicity in spleen of conscious rat.

Authors:  N Shimizu; Y Kaizuka; T Hori; H Nakane
Journal:  Am J Physiol       Date:  1996-09

2.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 3.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

4.  Cold-induced stress increases the intensity of Chlamydia genital infection in mice.

Authors:  Tesfaye Belay; Anthony Woart
Journal:  J Microbiol Immunol Infect       Date:  2012-07-11       Impact factor: 4.399

5.  Adaptive immunity in mice lacking the beta(2)-adrenergic receptor.

Authors:  Virginia M Sanders; Deborah J Kasprowicz; Michelle A Swanson-Mungerson; Joseph R Podojil; Adam P Kohm
Journal:  Brain Behav Immun       Date:  2003-02       Impact factor: 7.217

6.  Norepinephrine modulates human dendritic cell activation by altering cytokine release.

Authors:  Earl Goyarts; Mary Matsui; Tom Mammone; Anna M Bender; John A Wagner; Daniel Maes; Richard D Granstein
Journal:  Exp Dermatol       Date:  2008-01-16       Impact factor: 3.960

7.  Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production.

Authors:  D S Ramer-Quinn; R A Baker; V M Sanders
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; F Alexander; D Taylor-Robinson
Journal:  J Exp Pathol (Oxford)       Date:  1990-06

9.  Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.

Authors:  Rodolfo D Vicetti Miguel; Nirk E Quispe Calla; Stephen D Pavelko; Thomas L Cherpes
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

10.  Mapping differentiation under mixed culture conditions reveals a tunable continuum of T cell fates.

Authors:  Yaron E Antebi; Shlomit Reich-Zeliger; Yuval Hart; Avi Mayo; Inbal Eizenberg; Jacob Rimer; Prabhakar Putheti; Dana Pe'er; Nir Friedman
Journal:  PLoS Biol       Date:  2013-07-30       Impact factor: 8.029

View more
  3 in total

1.  Active Hexose-Correlated Compound Restores Gene Expression and Protein Secretion of Protective Cytokines of Immune Cells in a Murine Stress Model during Chlamydia muridarum Genital Infection.

Authors:  Tesfaye Belay; Rajnish Sahu; Elisha Martin; Kristin Brown; Courtney Rolen; Shomonique Hankins; Brianna Punturi; Maya Patterson; Chase Chambers; Brandon Kirby; Jonathan Butchar
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

2.  The Role of β-Adrenergic Receptors in the Regulation of the Functions of Innate Immune Cells during Cold Stress In Vivo.

Authors:  S V Gein; A V Karnaukhova
Journal:  Bull Exp Biol Med       Date:  2022-05-26       Impact factor: 0.804

Review 3.  Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions.

Authors:  Jaciara Fernanda Gomes Gama; Liana Monteiro da Fonseca Cardoso; Rodrigo da Cunha Bisaggio; Jussara Lagrota-Candido; Andrea Henriques-Pons; Luiz A Alves
Journal:  Cells       Date:  2022-07-29       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.